Skip to main content
Literatur
1.
Zurück zum Zitat Adli M, Hegerl U (2014) Do we underestimate the benefits of antidepressants? Lancet 383(9926):1361–1362CrossRefPubMed Adli M, Hegerl U (2014) Do we underestimate the benefits of antidepressants? Lancet 383(9926):1361–1362CrossRefPubMed
2.
Zurück zum Zitat American Psychiatric Association (APA) (2010) Work group on major depressive disorder. Practice guideline for the treatment of patients with major depressive disorder. (Third Edition). http://psychiatryonline.org/pb/assets/raw/ sitewide/practice_guidelines/guidelines/mdd. pdf. Zugegriffen: 11.10.2015 American Psychiatric Association (APA) (2010) Work group on major depressive disorder. Practice guideline for the treatment of patients with major depressive disorder. (Third Edition). http://​psychiatryonline​.​org/​pb/​assets/​raw/​ sitewide/practice_guidelines/guidelines/mdd. pdf. Zugegriffen: 11.10.2015
3.
Zurück zum Zitat Anderson IM (2000) Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a Meta-analysis of efficacy and tolerability. J Affect Disord 58(1):19–36CrossRefPubMed Anderson IM (2000) Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a Meta-analysis of efficacy and tolerability. J Affect Disord 58(1):19–36CrossRefPubMed
4.
Zurück zum Zitat Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard L, Lewis G, Matthews K, McAllister-Williams RH, Peveler RC, Scott J, Tylee A (2008) Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol 22(4):343–396CrossRefPubMed Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard L, Lewis G, Matthews K, McAllister-Williams RH, Peveler RC, Scott J, Tylee A (2008) Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol 22(4):343–396CrossRefPubMed
5.
Zurück zum Zitat Barbui C, Hotopf M, Freemantle N, Boynton J, Churchill R, Eccles MP, Geddes JR, Hardy R, Lewis G, Mason JM (2007) WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs). Cochrane Database Syst Rev 18(3):CD002791 Barbui C, Hotopf M, Freemantle N, Boynton J, Churchill R, Eccles MP, Geddes JR, Hardy R, Lewis G, Mason JM (2007) WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs). Cochrane Database Syst Rev 18(3):CD002791
6.
Zurück zum Zitat Bauer M, Pfennig A, Severus E, Whybrow PC, Angst J, Möller HJ (2013) World Federation of Societies of Biological Psychiatry. Task Force on Unipolar Depressive Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders. World J Biol Psychiatry 14(5):334–385CrossRefPubMed Bauer M, Pfennig A, Severus E, Whybrow PC, Angst J, Möller HJ (2013) World Federation of Societies of Biological Psychiatry. Task Force on Unipolar Depressive Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders. World J Biol Psychiatry 14(5):334–385CrossRefPubMed
7.
Zurück zum Zitat Bauer M, Monz BU, Montejo AL, Quail D, Dantchev N, Demyttenaere K, Garcia-Cebrian A, Grassi L, Perahia DG, Reed C, Tylee A (2008) Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study. Eur Psychiatry 23(1):66–73CrossRefPubMed Bauer M, Monz BU, Montejo AL, Quail D, Dantchev N, Demyttenaere K, Garcia-Cebrian A, Grassi L, Perahia DG, Reed C, Tylee A (2008) Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study. Eur Psychiatry 23(1):66–73CrossRefPubMed
8.
Zurück zum Zitat DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW (2009) S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression – Langfassung. DGPPN, ÄZQ, AWMF, Berlin, Düsseldorf DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW (2009) S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression – Langfassung. DGPPN, ÄZQ, AWMF, Berlin, Düsseldorf
9.
Zurück zum Zitat DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW (2015) S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression – Langfassung. 2. Auflage, Konsultationsfassung – Stand: 20.07.2015. http://www.leitlinien.de/mdb/downloads/nvl/depression/depression-2aufl-konsultation.pdf. Zugegriffen: 11.10.2015 DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW (2015) S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression – Langfassung. 2. Auflage, Konsultationsfassung – Stand: 20.07.2015. http://​www.​leitlinien.​de/​mdb/​downloads/​nvl/​depression/​depression-2aufl-konsultation.​pdf.​ Zugegriffen: 11.10.2015
10.
Zurück zum Zitat Gaebel W, Kowitz S, Fritze J, Zielasek J (2013) Inanspruchnahme des Versorgungssystems bei psychischen Erkrankungen. Sekundärdaten von drei gesetzlichen Krankenkassen und der Deutschen Rentenversicherung Bund. Dtsch Arztebl Int 110(47):799–808PubMedPubMedCentral Gaebel W, Kowitz S, Fritze J, Zielasek J (2013) Inanspruchnahme des Versorgungssystems bei psychischen Erkrankungen. Sekundärdaten von drei gesetzlichen Krankenkassen und der Deutschen Rentenversicherung Bund. Dtsch Arztebl Int 110(47):799–808PubMedPubMedCentral
11.
Zurück zum Zitat Geddes JR, Freemantle N, Mason J, Eccles MP, Boynton J (2007) WITHDRAWN: Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression. Cochrane Database Syst Rev 18(3):CD001851 Geddes JR, Freemantle N, Mason J, Eccles MP, Boynton J (2007) WITHDRAWN: Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression. Cochrane Database Syst Rev 18(3):CD001851
12.
Zurück zum Zitat Glassman AH, Walsh BT, Roose SP, Rosenfeld R, Bruno RL, Bigger JT Jr, Giardina EG (1982) Factors related to orthostatic hypotension associated with tricyclic antidepressants. J Clin Psychiatry 43(5 Pt 2):35–38PubMed Glassman AH, Walsh BT, Roose SP, Rosenfeld R, Bruno RL, Bigger JT Jr, Giardina EG (1982) Factors related to orthostatic hypotension associated with tricyclic antidepressants. J Clin Psychiatry 43(5 Pt 2):35–38PubMed
13.
Zurück zum Zitat Hotopf M, Hardy R, Lewis G (1997) Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity. Br J Psychiatry 170:120–127CrossRefPubMed Hotopf M, Hardy R, Lewis G (1997) Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity. Br J Psychiatry 170:120–127CrossRefPubMed
14.
Zurück zum Zitat Knegtering HM, Huijsman E, Huijsman A (1994) Effects of antidepressants on cognitive functioning of elderly patients. A review. Drugs Aging 5(3):192–199CrossRefPubMed Knegtering HM, Huijsman E, Huijsman A (1994) Effects of antidepressants on cognitive functioning of elderly patients. A review. Drugs Aging 5(3):192–199CrossRefPubMed
15.
Zurück zum Zitat Lam RW, Kennedy SH, Grigoriadis S, McIntyre RS, Milev R, Ramasubbu R, Parikh SV, Patten SB, Ravindran AV (2009) Canadian Network for Mood and Anxiety Treatments (CANMAT). Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. J Affect Disord 117(Suppl 1):26–43CrossRef Lam RW, Kennedy SH, Grigoriadis S, McIntyre RS, Milev R, Ramasubbu R, Parikh SV, Patten SB, Ravindran AV (2009) Canadian Network for Mood and Anxiety Treatments (CANMAT). Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. J Affect Disord 117(Suppl 1):26–43CrossRef
16.
Zurück zum Zitat Linde K, Kriston L, Rücker G, Jamil S, Schumann I, Meissner K, Sigterman K, Schneider A (2015) Efficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysis. Ann Fam Med 13(1):69–79CrossRefPubMedPubMedCentral Linde K, Kriston L, Rücker G, Jamil S, Schumann I, Meissner K, Sigterman K, Schneider A (2015) Efficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysis. Ann Fam Med 13(1):69–79CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Luppa M, Sikorski C, Luck T et al (2012) Age- and gender-specific prevalence of depression in latest-life – systematic review and meta-analysis. J Affect Disord 136:212–221CrossRefPubMed Luppa M, Sikorski C, Luck T et al (2012) Age- and gender-specific prevalence of depression in latest-life – systematic review and meta-analysis. J Affect Disord 136:212–221CrossRefPubMed
19.
Zurück zum Zitat Roose SP (2001) Depression, anxiety, and the cardiovascular system: the psychiatrist’s perspective. J Clin Psychiatry 62(Suppl 8):19–22PubMed Roose SP (2001) Depression, anxiety, and the cardiovascular system: the psychiatrist’s perspective. J Clin Psychiatry 62(Suppl 8):19–22PubMed
20.
Zurück zum Zitat Wissenschaftliches Institut der AOK (WIdO) (2014) Klauber, Günster, Gerste, Robra, Schmacke (Hrsg.). Versorgungs-Report 2013/2014. Schwerpunkt: Depression. Schattauer, Stuttgart Wissenschaftliches Institut der AOK (WIdO) (2014) Klauber, Günster, Gerste, Robra, Schmacke (Hrsg.). Versorgungs-Report 2013/2014. Schwerpunkt: Depression. Schattauer, Stuttgart
Metadaten
Titel
Trizyklische Antidepressiva zur Initialbehandlung einer depressiven Episode? Kontra
verfasst von
PD Dr. M. Adli
M. Berger
Publikationsdatum
01.12.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Der Nervenarzt / Ausgabe 5/2016
Print ISSN: 0028-2804
Elektronische ISSN: 1433-0407
DOI
https://doi.org/10.1007/s00115-015-0032-6

Weitere Artikel der Ausgabe 5/2016

Der Nervenarzt 5/2016 Zur Ausgabe